ULTA BEAUTY, INC. (ULTA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $517.11, ULTA BEAUTY, INC. (ULTA) is priced for +2.5% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Exported: 2026-08-31 · Source: https://boothcheck.com/report/ULTA

Headline

FieldValue
TickerULTA
CompanyULTA BEAUTY, INC.
Sector / IndustryConsumer Cyclical
Current price$517.11/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)2.6%
Operating margin today12.5%
Margin compression (value-band)-9.9pp
Implied growth2.5%
Multiple paid15x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.4% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.90σ
cohort percentile (of 212 peers)39

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.69x5expensive
Earnings1.61x4expensive
Relative1.14x5expensive
Growth0.64x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.7%); the inversion above states its own rate.

Per-Model Detail (n=17)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$887.670.58xyesFCF base $1.2B, growth 11% (input: historical growth), terminal g 4.0%, WACC 8.7%, 6yr projection
DCF Exit MultipleGrowth$805.880.64xyesExit EV/EBITDA: 10.7x / 12.7x / 14.7x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$603.650.86xyesP/E 20x (static sector reference · 2026-04), scenarios: 16.6x / 20.0x / 23.4x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$305.941.69xyesBV/sh $61.83, ROE (TTM) 45.8%, ke 9.3%
Two-Stage Excess ReturnAsset$796.690.65xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$587.940.88xyesRev $13.0B, growth 11% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$329.401.57xyesEPS $27.45, growth 8% (input: historical EPS growth), PEG=2.29 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$351.851.47xyesNormalized EBIT (5y avg op income, one-time charges added back) $1.58B × (1−21%) / WACC 8.7% → EPV (no growth)
Residual IncomeAsset$491.171.05xyesBV $61.83 + 5yr PV of (ROE (TTM) 45.8% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$195.422.65xyes√(22.5 × EPS $27.45 × BVPS $61.83) — Graham's conservative floor
EV/EBITDA RelativeRelative$578.100.89xyesEBITDA $1.93B × sector EV/EBITDA 14.0x
FCF YieldEarnings$235.302.20xyesFCF $1149.5M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$563.340.92xyesEPS $27.45 × (8.5 + 2×8.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$42.5212.16xyesBV $61.83 × (ROIC 6.0% / WACC 8.7%)
P/Sales SectorRelative$454.501.14xyesRevenue $12.96B × sector P/S 1.5x
PEG Fair ValueRelative$329.131.57xyesEPS $27.45 × (PEG 1.5 × growth 8.0% (input: historical EPS growth)) → PE 12.0x
Earnings YieldEarnings$296.761.74xyesEPS $27.45 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

Only one reportable economic unit is present in the current topology source. Consolidated operating lenses remain available, but there is no multi-unit decomposition.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Specialty beauty retail (single segment)operatingenterprise11.3B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$126.1m
Net debt / NOPAT (after-tax)0.10x
Net debt / operating income (pre-tax)0.08x
Share count CAGR (buyback)-4.6%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Work out what the price is asking for and the bull case largely writes itself. At about 15 times company-wide operating income, today's quote resolves into a requirement that operating profit grow roughly 2.2% a year over five years. Read that again, because it is not the double-digit pace a premium retailer's price usually demands. That is the level of performance a buyer at $474.98 needs in order to be made whole on the arithmetic, and it is roughly the pace of inflation.

Now set that against what the company reported for its most recent quarter. "Net sales increased $315.5 million, or 11.1%, to $3.2 billion" for the thirteen weeks to May 2, 2026, and "The total comparable sales increase of 5.3%" for that period "was driven by a 3.7% increase in average ticket and a 1.6% increase in transactions". Both parts moved in the right direction, and gross profit took 40.1% of net sales in that quarter against 39.1% a year earlier. A retailer holding price, growing basket size, adding visits and expanding merchandise margin at the same time is not a business in trouble, and it does not need much to clear a 2.2% hurdle.

The reason the numbers behave that way sits in the loyalty file. Management stated in June that over 95% of sales come from program members, which turns what looks like a chain of stores into something closer to a subscription database with shelves attached. That changes the economics of every marketing dollar, because the company is mostly talking to people it can already identify, and it changes the risk profile of a new store, since the members in a catchment area are visible before the lease is signed. The physical footprint stays cheap by retail standards: the annual report puts the average investment to open a new U.S. store at "approximately $2.4 million, which includes capital investments, net of landlord contributions, pre-opening expenses, and initial inventory, net of payables", spread across a network the latest filing describes as "1,608 stores worldwide: 1,521 Ulta Beauty stores in the U.S. located in 50 states, 85 Space NK stores located in the United Kingdom (U.K.), and 2 Space NK stores located in Ireland".

Then there is the quieter compounding. The share count has fallen about 4.4% a year over the four years to May 2026. When the growth the price requires is barely above inflation, buying back a twentieth of the company annually is not a supplementary return; it is most of the thesis. Funded borrowings are trivial next to the cash on hand, so that program is running out of operating cash flow rather than out of the credit market, which is the version that survives a bad year.

Bear Case

Look at where the capital actually goes, because the visible allocation and the real one are different. What shows up in the headlines is the buyback, roughly a twentieth of the shares a year. What does not show up on the debt line is the lease book, and for a chain of this size the lease book is the balance sheet. The quarterly filing carries operating lease liabilities of about 310 million dollars current and roughly 1.85 billion dollars non-current, so the obligation the company has genuinely committed to sits near 2.3 billion dollars on a lease-inclusive basis, against a modest net cash position of about 76 million dollars measured on funded borrowings alone. Both figures are true; they answer different questions. Rent is contractual and long-dated, comparable sales are neither, and that asymmetry is what makes a store-based retailer fragile in a way the funded-debt line never shows.

The second concern is who holds the pricing power in the supply chain. The annual report is direct: "During fiscal 2025 and fiscal 2024, merchandise supplied by our top ten brand partners accounted for approximately 51% and 54% of our net sales, respectively. There continues to be vendor consolidation within the beauty products industry". Half the sales come from ten counterparties, each of which also sells directly to consumers and into competing retailers, and each of which gets stronger as the industry consolidates. A retailer whose differentiation is assortment is only as differentiated as its suppliers permit, and the terms of that permission are renegotiated continuously.

There is also a quality question inside the good headline number. The recent comparable sales increase came mostly from ticket rather than traffic: "was driven by a 3.7% increase in average ticket and a 1.6% increase in transactions". Ticket-led comps are the pattern that flatters a beauty retailer late in a cycle, when premiumization carries the number and the underlying visit count is doing much less. Meanwhile the international expansion is currently a cost: the quarterly filing shows selling, general and administrative expenses rising to 25.8% of net sales from 24.9%, attributing the increase primarily to the acquisition of Space NK. Buying growth is a legitimate strategy, but it arrives as expense first and as margin later, if at all.

None of this is an argument that the price is stretched. The peer-multiple methods sit close to today's quote and the forward-growth methods land above it; only the asset and earnings-power lenses land below. The bear case here is narrower and more specific: the price needs only about 2.2% annual operating growth, so the question is not whether the market has over-extrapolated but whether a lease-heavy retailer with half its sales sourced from ten vendors can miss even a modest bar in a soft consumer year. The competitive field described in the annual report is wide, running from "regional and national department stores, catalog retailers, local specialty retail stores, and direct response television" to salon chains, and the discount rate itself is a live variable: each additional percentage point of cost of capital shifts the growth the price requires by about 6.2 points. That is the sensitivity of a modest bar to an immodest change in rates.

Valuation

Begin with the requirement rather than the multiple. At about 15 times company-wide operating income, the price embeds operating profit growing roughly 2.2% a year across a five-year stage, computed at about an 8.4% cost of capital with 4% growth assumed after that. These are approximations from one pass rather than measurements, but the level is the point: the price is not asking this company to do anything remarkable. It is asking it to keep pace with prices.

Set against the company's own recent record, that is a low bar; the business has been growing several times faster than the rate the price needs. The overall read on what the price assumes is that it sits within the range of ordinary outcomes rather than at the edge of them.

The methods split in a way that confirms a value-supported reading rather than a growth premium. The forward-growth approaches land above today's price, the peer-multiple methods land close to it, and the earnings-power and asset-based approaches land below. The mechanism at the low end is worth naming: the earnings-power lens averages five years of operating profit and then capitalizes that average as though the company never grows again, which for a chain that has been opening stores throughout the averaging window is a floor rather than a fair reading. When the pattern looks like this, the price is being defended by what comparable companies fetch and by forward cash flows, not by a bet that the static approaches cannot express.

The cohort comparison is where the case gets concrete, because this group is largely standing still. WSM earned an 18.0% operating margin on $7.88 billion of revenue while growing revenue 1.3%; BBWI earned 15.8% on $7.25 billion with revenue down 1.4%; SIG at 5.6%, VSCO at 4.8%, SBH at 8.2% on $3.73 billion, and BBY at 3.7% on $41.86 billion fill in the rest of the range. Against that, trailing operating profit of $1.50 billion on $12.71 billion of revenue is at the upper end of the group's profitability, and the recent comparable sales figure is well ahead of the revenue growth any of these names is posting. The multiple attached to that position is not a premium one.

Two balance-sheet readings are both worth having, and they are not in conflict once the basis is named. On funded borrowings against cash, the company holds net cash of about 76 million dollars. Include capitalized store leases, which for a 1,608-store chain is the more economically honest frame, and committed obligations run to roughly 2.3 billion dollars. Either way the company is a long distance from financial stress, and the share count has been falling about 4.4% a year over the four years to May 2026. What the price rests on is not the balance sheet and not the multiple. It is whether a modest growth requirement stays modest.

Catalysts

The next scheduled print is second-quarter results on August 27, 2026. The last one, released June 18, 2026 and covering the thirteen weeks to May 2, 2026, set the bar it will be read against: "Net sales increased $315.5 million, or 11.1%, to $3.2 billion" with "The total comparable sales increase of 5.3%". The specific line to watch is the transactions component, which contributed 1.6 points of that comp against 3.7 points from average ticket, because a comp that keeps leaning on ticket is a different quality of number than one where visits are returning.

The most concrete new development is a partnership with Bath & Body Works announced June 23, 2026, placing curated selections from that brand in more than 600 Ulta Beauty stores from July 12. This is not a pilot at the margins: BBWI is a peer of real scale in this cohort, running a 15.8% operating margin on $7.25 billion of revenue, and the arrangement pools traffic between two specialty retailers rather than adding another undifferentiated vendor to the assortment. The August print covers the first weeks of that rollout, though a meaningful read on productivity per store will take longer.

Two internal changes sit behind the numbers. The company named Kelly Garcia chief technology officer effective August 31, 2026, a notable appointment for a retailer whose loyalty database does most of the marketing work. And the Space NK business acquired in the United Kingdom and Ireland is still in its expensive phase: the last quarterly filing attributed the rise in selling, general and administrative expenses as a share of net sales primarily to that acquisition. Whether international scale starts paying for itself is a question the next few reports will begin to answer.

Peer Cohorts (Per Segment, With Filing Citations)

Specialty beauty retail (single segment) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

company earnings calendar via stockanalysis.com, July 2026 · Form 10-Q for the quarter ended May 2, 2026 · company remarks reported June 18, 2026 · partnership announcement, June 23, 2026 · company announcement, July 14, 2026

View the full interactive ULTA report on boothcheck